All Stories

  1. Safety and efficacy of elbasvir/grazoprevir for the treatment of chronic hepatitis C: current evidence

    Article • Drug Design Development and Therapy, September 2018, Dove Medical Press

    Dr Kenichi Morikawa

  2. L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis

    Article • Hepatology Communications, August 2018, Wiley

    Dr Kenichi Morikawa

  3. Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction

    Article • Hepatology Research, February 2018, Wiley

    Dr Kenichi Morikawa

  4. Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis

    Article • Hepatology Research, November 2017, Wiley

    Dr Kenichi Morikawa

  5. Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study

    Article • Hepatology Research, August 2017, Wiley

    Dr Kenichi Morikawa

  6. Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based therapies for hepatitis C

    Article • Journal of Viral Hepatitis, July 2017, Wiley

    Dr Kenichi Morikawa

  7. Hepatitis B virus reactivation during hepatitis C direct-acting antiviral therapy in patients with previous HBV infection

    Article • Journal of Hepatology, April 2017, Elsevier

    Dr Kenichi Morikawa

  8. Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment

    Article • Hepatology Research, January 2017, Wiley

    Dr Kenichi Morikawa

  9. Viral life cycle of hepatitis B virus: Host factors and druggable targets

    Article • Hepatology Research, February 2016, Wiley

    Dr Kenichi Morikawa

  10. Increased expression of immuno-inhibitory molecules on peripheral blood lymphocytes may suppress disease progression in autoimmune hepatitis

    Article • Hepatology Research, November 2015, Wiley

    Dr Kenichi Morikawa

  11. Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage

    Article • Journal of Hepatology, April 2015, Elsevier

    Dr Kenichi Morikawa

  12. Quantitative proteomics identifies the membrane-associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3-4A protease

    Article • Hepatology, December 2013, Wolters Kluwer Health

    Dr jerome Gouttenoire, Dr Kenichi Morikawa

  13. Replication and infectivity of a novel genotype 1b hepatitis C virus clone

    Article • Microbiology and Immunology, April 2012, Wiley

    Dr Kenichi Morikawa

  14. Production and characterization of HCV particles from serum-free culture

    Article • Vaccine, June 2011, Elsevier

    Dr Kenichi Morikawa

  15. Nonstructural protein 3‐4A: the Swiss army knife of hepatitis C virus

    Article • Journal of Viral Hepatitis, March 2011, Wiley

    Dr jerome Gouttenoire, Dr Kenichi Morikawa

  16. Magnitude of CD8+T-cell responses against hepatitis C virus and severity of hepatitis do not necessarily determine outcomes in acute hepatitis C virus infection

    Article • Hepatology Research, March 2009, Wiley

    Dr Kenichi Morikawa

  17. An infectious and selectable full-length replicon system with hepatitis C virus JFH-1 strain

    Article • Hepatology Research, June 2007, Wiley

    Dr Kenichi Morikawa

  18. The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles

    Article • Journal of Medical Virology, January 2007, Wiley

    Dr Kenichi Morikawa

  19. Translational enhancement of HCV RNA genotype 1b by 3′-untranslated and envelope 2 protein-coding sequences

    Article • Virology, February 2006, Elsevier

    Dr Kenichi Morikawa, Takeshi Saito

  20. Sequence analysis of PePHD within HCV E2 region and correlation with resistance of interferon therapy in Japanese patients infected with HCV genotypes 2a and 2b

    Article • The American Journal of Gastroenterology, June 2003, Nature

    Dr Kenichi Morikawa, Takeshi Saito

  21. Conserved Sequence and Function of HCV Core Protein in HCV-infected Patients with and Without Hepatocellular Carcinoma

    Article • The Showa University Journal of Medical Sciences, January 2003, The Showa University Society

    Dr Kenichi Morikawa